ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2726

CD28null T Cells from Polymyositis Patients Are Cytotoxic to Autologous Muscle Cells in Vitro Via Perforin-Dependent Mechanisms

Jayesh Pandya1, Paulius Venalis1, Lubna Al-Khalili2, Mohammad Shahadat Hossain1, Ingrid E. Lundberg1, Vivianne Malmström1 and Andreas E. R. Fasth1, 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 2Division of Industrial Biotechnology, KTH - Royal Institute of Technology, Stockholm, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, CD8 cells, myopathy and polymyositis, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Inflammatory infiltrates of muscles in polymyositis are dominated by CD4+CD28null and CD8+CD28null T cells. In contrast to conventional CD28+ T cells, these cells have a restricted T cell-receptor repertoire, rapidly release large amounts of IFN-γ and TNF, and can kill tissue cells by granzyme-B and perforin upon activation. Although their presence in myositis muscles have been demonstrated recently, their effect on muscle cells has not been clarified. Aim of the study was to investigate the potential myotoxic effect of CD28null T cells on muscle cells from patients with polymyositis, in a fully autologous co-culture system.

Methods: Muscle stem cells were extracted from biopsies from 6 patients with polymyositis (classified according to Bohan and Peter criteria) and differentiated into myotubes. T cell subsets from the same patients were isolated from peripheral blood by flow-cytometry. Co-cultures of autologous muscle cells were performed with un-stimulated or stimulated T cell subsets for 24-36 hours. Dead myotubes were quantified by calcein release assay and flow-cytometry. Blocking experiments were performed using relevant blocking antibodies to the co-cultures.

Results: CD28null T cells were spontaneously cytotoxic to autologous muscle cells in culture. The median cytotoxicity (induced muscle cell death) at 5:1 T cells-muscle cells ratio was 23.5% for CD4+CD28null and 22.3% for CD8+CD28null T cell subsets (n=4). In comparison, conventional CD4+ and CD8+ T cells displayed lower cytotoxicity (median CD4+CD28+ 10.3%, CD8+CD28+ 11.4%, n=4). Upon co-culture in stimulatory environment, both CD28null T cell subsets significantly induced more cell death in autologous muscle cells than CD28+ counterparts (n=5). Not only CD8+CD28null but also CD4+CD28null T cells displayed perforin polarization towards muscle cells and secreted higher levels of granzyme-B and IFN-γ in co-culture than CD28+ subsets (n=4). By blocking perforin, the myotoxicity was reduced by a median of 52% with CD4+CD28null T cells and by 56% in cultures with CD8+CD28null T-cells (n=3). TNF or IFN-γ did not induce death of muscle cells in the absence of T cells, but did upregulate HLA class I and II on muscle cells (n=3-5). Blockade of IFN-γ and TNF in co-cultures with T cells reduced the level of dead muscle cells by 46% (CD4+CD28null) and 53% (CD8+CD28null) (n=3). The reduced myotoxicity is likely attributed to reduced HLA expression, as HLA blockade resulted in a comparable reduction in myotoxicity, 61% (CD4+CD28null) and 55% (CD8+CD28null) (n=5).

Conclusion:  The myotoxic effect by CD28null T cells in polymyositis may be mediated by perforin-dependent killing and regulated by IFN-γ-induced HLA expression by muscle cells. Together, this suggests that CD28null T cells are key effector cells directly contributing to the muscle cell damage in polymyositis, hence represent target candidate for future therapies


Disclosure:

J. Pandya,
None;

P. Venalis,
None;

L. Al-Khalili,
None;

M. S. Hossain,
None;

I. E. Lundberg,

Research grants from Bristol-Myers Squibb and Astra-Seneca,

2,

Scientific advisor at Novartis, Servier and aTYR,

6;

V. Malmström,
None;

A. E. R. Fasth,

Employed by Novartis,

3.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd28null-t-cells-from-polymyositis-patients-are-cytotoxic-to-autologous-muscle-cells-in-vitro-via-perforin-dependent-mechanisms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology